BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15787606)

  • 1. Modulation of insulin signalling by insulin sensitizers.
    Jiang G; Zhang BB
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):358-61. PubMed ID: 15787606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
    Gual P; Le Marchand-Brustel Y; Tanti JF
    Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes.
    Danielsson A; Ost A; Lystedt E; Kjolhede P; Gustavsson J; Nystrom FH; Strålfors P
    FEBS J; 2005 Jan; 272(1):141-51. PubMed ID: 15634339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes.
    Ost A; Danielsson A; Lidén M; Eriksson U; Nystrom FH; Strålfors P
    FASEB J; 2007 Nov; 21(13):3696-704. PubMed ID: 17575262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts.
    Bertacca A; Ciccarone A; Cecchetti P; Vianello B; Laurenza I; Maffei M; Chiellini C; Del Prato S; Benzi L
    Metabolism; 2005 Dec; 54(12):1687-93. PubMed ID: 16311104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
    Jiang G; Dallas-Yang Q; Li Z; Szalkowski D; Liu F; Shen X; Wu M; Zhou G; Doebber T; Berger J; Moller DE; Zhang BB
    Diabetes; 2002 Aug; 51(8):2412-9. PubMed ID: 12145152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refeeding and insulin activate the AKT/p70S6 kinase pathway without affecting IRS1 tyrosine phosphorylation in chicken muscle.
    Duchêne S; Métayer S; Audouin E; Bigot K; Dupont J; Tesseraud S
    Domest Anim Endocrinol; 2008 Jan; 34(1):1-13. PubMed ID: 17029674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
    Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of IRS1 at serine 307 and serine 312 in response to insulin in human adipocytes.
    Danielsson A; Nystrom FH; Strålfors P
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1183-7. PubMed ID: 16516141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
    Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
    J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E; Wong V; Guan X; Oprescu AI; Giacca A
    J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.
    Ruiz-Alcaraz AJ; Liu HK; Cuthbertson DJ; McManus EJ; Akhtar S; Lipina C; Morris AD; Petrie JR; Hundal HS; Sutherland C
    Biochem J; 2005 Dec; 392(Pt 2):345-52. PubMed ID: 16128672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aging on insulin signalling pathway is tissue dependent: central role of adipose tissue in the insulin resistance of aging.
    Serrano R; Villar M; Gallardo N; Carrascosa JM; Martinez C; Andrés A
    Mech Ageing Dev; 2009 Mar; 130(3):189-97. PubMed ID: 19063913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade.
    Lancaster GI; Skiba B; Yang C; Nicholls HT; Langley KG; Chan MH; Bruce CR; Rewcastle GW; Shepherd PR; Karin M; Febbraio MA
    Biochem J; 2012 Mar; 442(3):723-32. PubMed ID: 22364283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.
    Hosooka T; Noguchi T; Kotani K; Nakamura T; Sakaue H; Inoue H; Ogawa W; Tobimatsu K; Takazawa K; Sakai M; Matsuki Y; Hiramatsu R; Yasuda T; Lazar MA; Yamanashi Y; Kasuga M
    Nat Med; 2008 Feb; 14(2):188-93. PubMed ID: 18204460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation.
    Ropelle ER; Pauli JR; Prada PO; de Souza CT; Picardi PK; Faria MC; Cintra DE; Fernandes MF; Flores MB; Velloso LA; Saad MJ; Carvalheira JB
    J Physiol; 2006 Dec; 577(Pt 3):997-1007. PubMed ID: 17008371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.